Format

Send to

Choose Destination
Eur J Pharmacol. 2009 May 1;609(1-3):40-4. doi: 10.1016/j.ejphar.2009.03.033. Epub 2009 Mar 20.

Icariin enhances neuronal survival after oxygen and glucose deprivation by increasing SIRT1.

Author information

1
Department of Neurology, Affiliated Drum Tower Hospital of Nanjing University Medical School, PR China.

Abstract

It has been reported that icariin protects neurons against ischemia/reperfusion injury. In this study, we found that icariin could enhance neuronal viability and suppress neuronal death after oxygen and glucose deprivation (OGD). Further study showed that neuroprotection by icariin was through the induction of Sirtuin type 1 (SIRT1), an effect that was reversed by SIRT1 inhibitor III and P38 inhibitor SB203580. SIRT1 is an endogenous gene of longevity, which increased neuronal viability and could be activated by stimulating the mitogen-activated protein kinase (MAPK) pathway. However, this study found that icariin activated the MAPK/P38 pathway, not the extracellular signal-regulated kinase (MAPK/ERK) or c-Jun N-terminal protein kinase (MAPK/JNK) to regulate SIRT1 expression. The results suggest that icariin may be developed into a neuroprotectant for ischemia-related brain injury.

PMID:
19303870
DOI:
10.1016/j.ejphar.2009.03.033
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center